Variant report
Variant | esv3359677 |
---|---|
Chromosome Location | chr4:175623727-175628225 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:175626881..175629090-chr4:175631041..175633038,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs202033687 | chr4:175623731-175623732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186802073 | chr4:175623744-175623745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577195735 | chr4:175623779-175623780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189750403 | chr4:175623780-175623781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559982245 | chr4:175623809-175623810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529091137 | chr4:175623820-175623821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548855386 | chr4:175623927-175623928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182055428 | chr4:175623940-175623941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143234416 | chr4:175623985-175623986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76976795 | chr4:175623986-175623987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570889469 | chr4:175624002-175624003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189152952 | chr4:175624005-175624006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547113112 | chr4:175624078-175624079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73867677 | chr4:175624113-175624114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs193038787 | chr4:175624145-175624146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4498113 | chr4:175624148-175624149 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs558997710 | chr4:175624150-175624151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183808665 | chr4:175624153-175624154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79693894 | chr4:175624198-175624199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188297683 | chr4:175624235-175624236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2171139 | chr4:175624314-175624315 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs577258399 | chr4:175624370-175624371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539800630 | chr4:175624385-175624386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553831637 | chr4:175624406-175624407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12508745 | chr4:175624432-175624433 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs12505229 | chr4:175624437-175624438 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs562709851 | chr4:175624465-175624466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531514981 | chr4:175624484-175624485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545372119 | chr4:175624495-175624496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112054538 | chr4:175624531-175624532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375665640 | chr4:175624573-175624574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12506873 | chr4:175624600-175624601 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs374536328 | chr4:175624635-175624636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535718474 | chr4:175624667-175624668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28688380 | chr4:175624678-175624679 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs529336654 | chr4:175624711-175624712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12506042 | chr4:175624715-175624716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs374166299 | chr4:175624730-175624731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542211913 | chr4:175624810-175624811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561189327 | chr4:175624833-175624834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374241669 | chr4:175624859-175624860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529900873 | chr4:175624904-175624905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191931182 | chr4:175624905-175624906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs59236895 | chr4:175624948-175624949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558039866 | chr4:175624970-175624971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571797909 | chr4:175624975-175624976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34791728 | chr4:175625064-175625065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545940976 | chr4:175625119-175625120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188505149 | chr4:175625127-175625128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553453340 | chr4:175625142-175625143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:175619600-175624000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr4:175624000-175624600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr4:175624600-175628400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:175628000-175629200 | Enhancers | Fetal Kidney | kidney |
5 | chr4:175628200-175630600 | Enhancers | A549 | lung |